T. Brumm Joshua's most recent trade in Dyne Therapeutics Inc was a trade of 209,412 Common Stock done at an average price of $5.5 . Disclosure was reported to the exchange on March 8, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.54 per share. | 08 Mar 2024 | 209,412 | 917,728 | - | 5.5 | 1,160,142 | Common Stock |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 209,412 | 133,269 | - | - | Stock option (right to buy) | |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, CEO & President | Sale of securities on an exchange or to another person at price $ 25.30 per share. | 08 Mar 2024 | 202,238 | 715,490 | - | 25.3 | 5,116,621 | Common Stock |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, CEO & President | Sale of securities on an exchange or to another person at price $ 26.72 per share. | 08 Mar 2024 | 160,670 | 554,820 | - | 26.7 | 4,293,102 | Common Stock |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.54 per share. | 08 Mar 2024 | 153,931 | 708,316 | - | 5.5 | 852,778 | Common Stock |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 153,931 | 0 | - | - | Stock option (right to buy) | |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.54 per share. | 08 Mar 2024 | 50,000 | 604,385 | - | 5.5 | 277,000 | Common Stock |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 50,000 | 83,269 | - | - | Stock option (right to buy) | |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, CEO & President | Sale of securities on an exchange or to another person at price $ 25.42 per share. | 08 Mar 2024 | 40,072 | 564,313 | - | 25.4 | 1,018,630 | Common Stock |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, CEO & President | Sale of securities on an exchange or to another person at price $ 26.10 per share. | 08 Mar 2024 | 9,928 | 554,385 | - | 26.1 | 259,121 | Common Stock |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, CEO & President | Sale of securities on an exchange or to another person at price $ 25.93 per share. | 08 Mar 2024 | 8,618 | 537,998 | - | 25.9 | 223,465 | Common Stock |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, CEO & President | Sale of securities on an exchange or to another person at price $ 26.12 per share. | 08 Mar 2024 | 7,769 | 546,616 | - | 26.1 | 202,926 | Common Stock |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, CEO & President | Sale of securities on an exchange or to another person at price $ 27.38 per share. | 08 Mar 2024 | 435 | 554,385 | - | 27.4 | 11,910 | Common Stock |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, CEO & President | Sale of securities on an exchange or to another person at price $ 25.85 per share. | 07 Mar 2024 | 9,086 | 554,385 | - | 25.8 | 234,873 | Common Stock |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.54 per share. | 29 Feb 2024 | 94,480 | 657,951 | - | 5.5 | 523,419 | Common Stock |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, CEO & President | Sale of securities on an exchange or to another person at price $ 29.23 per share. | 29 Feb 2024 | 74,090 | 564,885 | - | 29.2 | 2,165,651 | Common Stock |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Feb 2024 | 57,843 | 44,500 | - | - | Stock option (right to buy) | |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Feb 2024 | 36,637 | 342,681 | - | - | Stock option (right to buy) | |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, CEO & President | Sale of securities on an exchange or to another person at price $ 28.25 per share. | 29 Feb 2024 | 18,976 | 638,975 | - | 28.3 | 536,072 | Common Stock |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.54 per share. | 29 Feb 2024 | 5,520 | 568,991 | - | 5.5 | 30,581 | Common Stock |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, CEO & President | Sale of securities on an exchange or to another person at price $ 27.50 per share. | 29 Feb 2024 | 5,520 | 563,471 | - | 27.5 | 151,800 | Common Stock |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Feb 2024 | 5,520 | 102,343 | - | - | Stock option (right to buy) | |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, CEO & President | Sale of securities on an exchange or to another person at price $ 29.70 per share. | 29 Feb 2024 | 1,414 | 563,471 | - | 29.7 | 41,996 | Common Stock |
| Dyne Therapeutics Inc | T. Brumm Joshua | Director, CEO & President | Gift of securities by or to the insider at price $ 0.00 per share. | 29 Jan 2024 | 20,000 | 564,971 | - | 0 | Common Stock | |
| Dyne Therapeutics Inc | T. Brumm Joshua | Director, CEO & President | Gift of securities by or to the insider at price $ 0.00 per share. | 29 Jan 2024 | 1,500 | 563,471 | - | 0 | Common Stock | |
| Dyne Therapeutics Inc | T. Joshua Brumm | CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.54 per share. | 03 Jan 2024 | 200,000 | 803,507 | - | 5.5 | 1,108,000 | Common Stock |
| Dyne Therapeutics Inc | T. Brumm Joshua | CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2024 | 200,000 | 107,863 | - | - | Stock option (right to buy) | |
| Dyne Therapeutics Inc | Brumm T. Joshua | CEO & President | Sale of securities on an exchange or to another person at price $ 18.40 per share. | 03 Jan 2024 | 180,235 | 623,272 | - | 18.4 | 3,316,324 | Common Stock |
| Dyne Therapeutics Inc | Brumm Joshua T. | CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2024 | 51,183 | 18,536 | - | - | Stock option (right to buy) | |
| Dyne Therapeutics Inc | Brumm T. Joshua | CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.03 per share. | 03 Jan 2024 | 51,183 | 636,154 | - | 1.0 | 52,718 | Common Stock |
| Dyne Therapeutics Inc | T. Joshua Brumm | CEO & President | Sale of securities on an exchange or to another person at price $ 19.05 per share. | 03 Jan 2024 | 38,301 | 584,971 | - | 19.0 | 729,634 | Common Stock |
| Dyne Therapeutics Inc | Joshua Brumm T. | CEO & President | Sale of securities on an exchange or to another person at price $ 19.03 per share. | 03 Jan 2024 | 19,775 | 600,997 | - | 19.0 | 376,318 | Common Stock |
| Dyne Therapeutics Inc | Brumm T. Joshua | CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2024 | 18,536 | 0 | - | - | Stock option (right to buy) | |
| Dyne Therapeutics Inc | T. Brumm Joshua | CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.03 per share. | 03 Jan 2024 | 18,536 | 603,507 | - | 1.0 | 19,092 | Common Stock |
| Dyne Therapeutics Inc | T. Brumm Joshua | CEO & President | Sale of securities on an exchange or to another person at price $ 20.50 per share. | 03 Jan 2024 | 16,026 | 584,971 | - | 20.5 | 328,533 | Common Stock |
| Dyne Therapeutics Inc | T. Joshua Brumm | CEO & President | Sale of securities on an exchange or to another person at price $ 18.34 per share. | 03 Jan 2024 | 15,382 | 620,772 | - | 18.3 | 282,106 | Common Stock |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 10.72 per share. | 11 Dec 2023 | 7,585 | 584,971 | - | 10.7 | 81,311 | Common Stock |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2023 | 358,877 | 592,556 | - | 0 | Common Stock | |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2023 | 139,750 | 139,750 | - | - | Stock Option (right to buy) | |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 9.41 per share. | 18 Sep 2023 | 12,032 | 233,679 | - | 9.4 | 113,221 | Common Stock |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 10.41 per share. | 12 Sep 2023 | 7,672 | 245,711 | - | 10.4 | 79,866 | Common Stock |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 12.61 per share. | 08 Jun 2023 | 187,748 | 253,383 | - | 12.6 | 2,367,502 | Common Stock |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.03 per share. | 08 Jun 2023 | 171,360 | 441,131 | - | 1.0 | 176,501 | Common Stock |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2023 | 171,360 | 69,719 | - | - | Stock Option (right to buy) | |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.03 per share. | 08 Jun 2023 | 76,582 | 346,353 | - | 1.0 | 78,879 | Common Stock |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 13.34 per share. | 08 Jun 2023 | 76,582 | 269,771 | - | 13.3 | 1,021,604 | Common Stock |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2023 | 76,582 | 241,079 | - | - | Stock Option (right to buy) | |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 13.15 per share. | 08 Jun 2023 | 46,811 | 283,960 | - | 13.2 | 615,565 | Common Stock |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.03 per share. | 08 Jun 2023 | 30,088 | 330,771 | - | 1.0 | 30,991 | Common Stock |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2023 | 30,088 | 317,661 | - | - | Stock Option (right to buy) | |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, See Remarks | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Jun 2023 | 20,000 | 302,483 | - | 0 | Common Stock | |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 13.47 per share. | 08 Jun 2023 | 14,189 | 269,771 | - | 13.5 | 191,126 | Common Stock |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, See Remarks | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Jun 2023 | 1,800 | 300,683 | - | 0 | Common Stock | |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 13.33 per share. | 14 Mar 2023 | 7,318 | 322,483 | - | 13.3 | 97,549 | Common Stock |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2022 | 222,000 | 222,000 | - | - | Stock Option (right to buy) | |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2022 | 144,000 | 333,123 | - | 0 | Common Stock | |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 10.87 per share. | 09 Dec 2022 | 3,322 | 329,801 | - | 10.9 | 36,110 | Common Stock |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Oct 2022 | 195,800 | 347,749 | - | - | Stock Option (right to buy) | |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 12.46 per share. | 07 Oct 2022 | 195,800 | 204,623 | - | 12.5 | 2,439,668 | Common Stock |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.03 per share. | 07 Oct 2022 | 195,800 | 400,423 | - | 1.0 | 201,674 | Common Stock |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.03 per share. | 07 Oct 2022 | 14,200 | 218,823 | - | 1.0 | 14,626 | Common Stock |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Oct 2022 | 14,200 | 543,549 | - | - | Stock Option (right to buy) | |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 13.37 per share. | 07 Oct 2022 | 14,200 | 204,623 | - | 13.4 | 189,854 | Common Stock |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, See Remarks | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Oct 2022 | 13,000 | 191,623 | - | 0 | Common Stock | |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, See Remarks | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Oct 2022 | 2,500 | 189,123 | - | 0 | Common Stock | |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, See Remarks | Sale or transfer of securities back to the company at price $ 13.70 per share. | 20 Sep 2022 | 11,836 | 204,623 | - | 13.7 | 162,153 | Common Stock |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, See Remarks | Sale or transfer of securities back to the company at price $ 14.05 per share. | 15 Sep 2022 | 3,480 | 216,459 | - | 14.1 | 48,894 | Common Stock |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2022 | 153,931 | 153,931 | - | - | Stock Option (right to buy) | |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2022 | 78,386 | 78,386 | - | - | Stock Option (right to buy) | |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2022 | 24,118 | 230,902 | - | 0 | Common Stock | |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, See Remarks | Sale or transfer of securities back to the company at price $ 8.24 per share. | 05 Jul 2022 | 10,963 | 219,939 | - | 8.2 | 90,335 | Common Stock |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, See Remarks | Sale or transfer of securities back to the company at price $ 4.95 per share. | 14 Jun 2022 | 3,540 | 206,784 | - | 5.0 | 17,523 | Common Stock |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 8.73 per share. | 11 Mar 2022 | 3,384 | 210,324 | - | 8.7 | 29,542 | Common Stock |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2021 | 177,285 | 177,285 | - | - | Stock Option (right to buy) | |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2021 | 118,190 | 213,708 | - | 0 | Common Stock | |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, See Remarks | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Oct 2021 | 3,500 | 95,518 | - | 0 | Common Stock | |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 16.11 per share. | 20 Sep 2021 | 4,584 | 99,018 | - | 16.1 | 73,848 | Common Stock |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 15.61 per share. | 20 Sep 2021 | 3,425 | 103,602 | - | 15.6 | 53,464 | Common Stock |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2020 | 320,781 | 320,781 | - | - | Stock Option (right to buy) | |
| Dyne Therapeutics Inc | Joshua T. Brumm | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2020 | 107,027 | 107,027 | - | 0 | Common Stock |